Active Biotech's virtual capital market day was held on November 24, 2020 with updates on our new direction, our clinical strategy and our project goals.

See all presentations here

Novel immunomodulatory treatments for patients with cancer or inflammatory diseases

Active Biotech focuses on the research and development of pharmaceuticals in therapeutic areas in which the immune system is of central importance. The project portfolio comprises therapy developed for the treatment of cancer and inflammatory diseases.

Diseases where the immune system is of central importance